GET DAILY SIGNALSSPY vs MODL: Weighing Passive Efficiency Against Active Sector Tilts
Key Takeaways
- MODL is an actively managed, semi-transparent U.S. sector ETF that tilts toward healthcare and utilities, while SPY is a passive, full-replication fund tracking the S&P 500 Index.
- SPY is dramatically cheaper, with a 0.09% expense ratio, versus roughly 0.46% for MODL, a meaningful long-term cost gap.
- SPY holds about 500 large-cap U.S. stocks and commands exceptional liquidity and scale; MODL holds roughly 360 names with a more concentrated, factor-driven sector emphasis.
- Both funds are dominated by mega-cap technology names, but MODL carries materially higher allocations to healthcare and utilities than SPY.
- Tickeron AI Verdict: SPY is the favored ticker in this comparison, based on cost efficiency, liquidity, diversification, and structural simplicity.
Why This Comparison Matters
For investors seeking broad U.S. large-cap equity exposure, few questions are more relevant than whether to accept the market as-is or pursue an actively tilted approach. The SPY and MODL comparison sits at the heart of that debate. SPY is the world’s best-known benchmark tracker, while MODL represents a newer, actively managed strategy that aims to emphasize U.S. sectors expected to outperform. They do not compete directly so much as offer alternative answers to the same goal: diversified U.S. equity ownership. Understanding their structural differences, sector exposure, cost profiles, and relative positioning helps investors decide which approach better fits their objectives in the current environment. I also checked this using Tickeron’s AI Screener to see how the two funds line up on key metrics.
A Closer Look at MODL
MODL is an actively managed, semi-transparent exchange-traded fund launched in October 2022 and advised by Victory Capital Management. Rather than tracking an index, the fund uses a multi-factor, sector-rotation approach to emphasize U.S. equity sectors it considers positioned to outperform, while maintaining diversified exposure across large-cap stocks.
The fund holds roughly 360 securities. Its top positions are concentrated in mega-cap technology names, including NVDA, AAPL, MSFT, GOOGL, META, AMZN, and AVGO, along with healthcare leaders ABBV and LLY. On a sector basis, technology is the largest allocation at roughly 40%, but MODL distinguishes itself with notably higher weightings to healthcare (around 16%) and utilities (around 10%) compared with the broad market, alongside financials and communication services. Its expense ratio is approximately 0.46%, and portfolio turnover is moderate as the strategy adjusts sector emphasis over time.
A Closer Look at SPY
SPY is a passively managed unit investment trust that seeks to replicate, before expenses, the price and yield performance of the S&P 500 Index. Launched in January 1993, it is the oldest and one of the largest ETFs in the world, holding approximately 500 of the largest publicly traded U.S. companies through full replication.
SPY’s top holdings mirror the index’s market-cap weighting, led by NVDA, AAPL, MSFT, AMZN, GOOGL, AVGO, META, and TSLA. Information technology accounts for roughly 38% to 44% of the fund, followed by financials, healthcare, consumer discretionary, communication services, and industrials. Its expense ratio is just 0.09%, and the fund’s enormous scale supports exceptionally tight bid-ask spreads and deep liquidity, making it a favored vehicle for both long-term investors and institutional traders.
Industry and Thematic Backdrop
Both ETFs are heavily shaped by the performance of U.S. mega-cap technology and the broader large-cap growth complex. Recent market cycles have been defined by artificial intelligence (AI) capital spending, semiconductor demand, and concentration among a handful of dominant companies, themes that lift both funds’ top holdings. At the same time, interest-rate expectations and macroeconomic data have driven periodic rotation between growth and defensive sectors such as healthcare and utilities.
This is where the two funds diverge. SPY’s sector weights simply reflect the market, so it carries limited direct utility and healthcare exposure. MODL’s active tilts toward healthcare and utilities give it a comparatively more defensive profile that may hold up differently during risk-off periods or rising rate volatility. Regulatory scrutiny of large technology platforms and evolving monetary policy remain key cross-cutting risks for both vehicles.
Performance and Positioning Comparison
In recent weeks and months, both funds have moved broadly in line with U.S. large-cap equities, with technology leadership a primary driver of returns. SPY’s performance has closely tracked the S&P 500, as expected, benefiting from the same mega-cap concentration that has lifted the index. MODL has produced broadly similar headline results but with different relative positioning: its overweight to healthcare and utilities has tended to temper volatility during defensive rotations, while its technology exposure keeps it correlated with the market’s dominant growth theme.
From a cost and efficiency standpoint, SPY’s 0.09% expense ratio gives it a structural advantage that compounds over time, while MODL’s roughly 0.46% fee requires its active sector tilts to add sufficient value to overcome the cost gap. MODL’s shorter track record and semi-transparent structure also make its relative positioning somewhat harder to verify in real time than SPY’s fully disclosed index replication.
Tickeron AI Verdict
Weighing observable factors, Tickeron’s AI currently favors SPY over MODL. SPY offers a materially lower expense ratio, deeper liquidity, a longer and more established track record, and full transparency through passive index replication, which reduces active-management risk. While MODL’s defensive tilts to healthcare and utilities provide a potentially valuable diversification benefit, that positioning comes at a meaningfully higher cost and with a shorter operating history. For most investors seeking broad, efficient U.S. large-cap exposure, SPY’s structural simplicity and cost efficiency present the more compelling risk-adjusted profile in the current environment.
Enhancing Research with Tickeron’s AI Screener
In my own work comparing funds like these, Tickeron’s AI Screener has become a go-to resource. It lets me quickly filter ETFs and stocks by technical patterns, fundamentals, trends, and AI signals, helping surface insights that might otherwise take hours of manual review. The customizable filters for industry, market cap, and performance metrics make it straightforward to evaluate positioning and opportunities side by side.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SPY in upward trend: price may jump up because it broke its lower Bollinger Band on November 05, 2026
SPY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 37 cases where SPY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 44 cases where SPY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPY advanced for three days, in 291 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPY as a result. In 57 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for SPY turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 39 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
SPY moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SPY crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for SPY entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Advertisement